CYBERMED LIFE - ORGANIC  & NATURAL LIVING

EXERCISE

Midlife Cardiorespiratory Fitness and the Long-Term Risk of Mortality: 46 Years of Follow-Up📎

Written by CYBERMED LIFE NEWS
Attachments:
Download this file (Midlife Cardiorespiratory Fitness and the Long-Term Risk of Mortality - 46 Years of Follow-Up..pdf)Midlife Cardiorespiratory Fitness and the Long-Term Risk of Mortality - 46 Years of Follow-Up..pdf[Midlife Cardiorespiratory Fitness and the Long-Term Risk of Mortality - 46 Years of Follow-Up.]714 kB
facebook Share on Facebook
Abstract Title:

Midlife Cardiorespiratory Fitness and the Long-Term Risk of Mortality: 46 Years of Follow-Up.

Abstract Source:

J Am Coll Cardiol. 2018 Aug 28 ;72(9):987-995. PMID: 30139444

Abstract Author(s):

Johan S R Clausen, Jacob L Marott, Andreas Holtermann, Finn Gyntelberg, Magnus T Jensen

Article Affiliation:

Johan S R Clausen

Abstract:

BACKGROUND: A high cardiorespiratory fitness (CRF) level is recommended to promote healthy aging. However, the association between CRF and very-long-term prognosis is unclear, and reverse causation may bias results in studies with shorter follow-up.

OBJECTIVES: This study investigated the association between CRF and mortality in middle-aged, employed men free of cardiovascular disease (CVD).

METHODS: Participants from the Copenhagen Male Study, established in 1970 to 1971, were included and stratified into 4 age-adjusted maximal oxygen consumption (Vomax) categories: below the lower limit of normal (lowest 5%); low normal (45%); high normal (45%); and above the upper limit of normal (top 5%). Vomax was estimated by using a bicycle ergometer. Multivariable restricted mean survival time models were performed for all-cause and cardiovascular mortality using Danish national registers.

RESULTS: A total of 5,107 men with a mean age of 48.8± 5.4 years were included in the study. During the 46 years of follow-up, 4,700 (92%) men died; 2,149 (42.1%) of the men died of CVD. Compared with below the lower limit of normal CRF, low normal CRF was associated with 2.1 years (95% confidence interval [CI]: 0.7 to 3.4; p = 0.002), high normalwith 2.9 years (95% CI: 1.5 to 4.2; p <0.001), and above upper limit of normal with 4.9 years (95% CI: 3.1 to 6.7; p < 0.001) longer mean life expectancy. Each unit increase in Vomax was associated with a 45-day (95% CI: 30 to 61; p <0.001) increase in longevity. Estimates for cardiovascular mortality were similar to all-cause mortality. Results were essentially unchanged when excluding individuals who died within the first 10 years of follow-up, suggesting a minimal role of reverse causation.

CONCLUSIONS: CRF was significantly related to longevity over the course of 4 decades in middle-aged, employed men free of CVD. The benefits of higher midlife CRF extend well into the later part of life.


We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.